DNA-蛋白质交联的诱导、修复和生物学后果--毒理学网
用户名:
密  码:

DNA-蛋白质交联的诱导、修复和生物学后果

来源:   浏览量:760   更新日期:2010年1月23日

DNA–protein crosslinks: their induction, repair, and biological consequences

Sharon Barker, Michael Weinfeld and David Murray

Department of Oncology, Division of Experimental Oncology, Cross Cancer Institute, 11560 University Avenue, University of Alberta, Edmonton, Alberta, Canada T6G 1Z2

Abstract

 The covalent crosslinking of proteins to DNA presents a major physical challenge to the DNA metabolic machinery. DNA–protein crosslinks (DPCs) are induced by a variety of endogenous and exogenous agents (including, paradoxically, agents that are known to cause cancer as well as agents that are used to treat cancer), and yet they have not received as much attention as other types of DNA damage. This review summarizes the current state of knowledge of DPCs in terms of their induction, structures, biological consequences and possible mechanisms of repair. DPCs can be formed through several different chemistries, which is likely to affect the stability and repair of these lesions, as well as their biological consequences. The considerable discrepancy in the DPC literature reflects both the varying chemistries of this heterogeneous group of lesions and the fact that a number of different methods have been used for their analysis. In particular, research in this area has long been hampered by the inability to chemically define these lesions in intact cells and tissues. However, the emergence of proteomics as a tool for identifying specific proteins that become crosslinked to DNA has heralded a new era in our ability to study these lesions. Although there are still many unanswered questions, the identification of specific proteins crosslinked to DNA should facilitate our understanding of the down-stream effects of these lesions.

Keywords: DNA–protein crosslink; DNA repair; DNA damage

1. Introduction

The purpose of this review is to summarize our current understanding of the mechanisms of induction and repair, as well as the biological consequences, of the types of DNA lesion known as DNA–protein crosslinks (DPCs). A DPC is created when a protein becomes covalently bound to DNA. Such events occur following exposure of cells to a variety of cytotoxic, mutagenic, and carcinogenic agents, including ultraviolet light and ionizing radiation (IR), metals and metalloids such as chromium, nickel and arsenic, various aldehydes, and some important chemotherapeutic drugs including cisplatin, melphalan, and mitomycin C. Humans are continuously exposed to DPC-inducing agents present in environmental pollutants such as cigarette smoke and automotive and diesel exhaust, industrial chemicals and foodstuffs, as well as physiological metabolites, such as products of lipid peroxidation. Understanding the biology of these lesions is complicated by several factors. For example, different agents induce DPCs by different mechanisms (Fig. 1). Proteins can become crosslinked to DNA directly through oxidative free radical mechanisms or they can be crosslinked indirectly through a chemical or drug linker or through coordination with a metal atom. A subtype of these crosslinking mechanisms involves a sulfhydryl linkage to the amino acid. This results in numerous types of DPCs that are chemically distinct and whose formation is influenced by factors such as cellular metabolism, cell-cycle phase, and temperature. It is likely that these different types of crosslinks will be more or less susceptible to various mechanisms of reversal (e.g., hydrolysis) and enzyme-catalyzed repair, given their different chemical structures and physical conformations. They may also have different cellular consequences.


Fig. 1. Crosslink structures. A schematic representation of two of the chemistries by which proteins may become crosslinked to DNA. (A) A formaldehyde induced crosslink between cytosine and lysine (taken from [169]). (B) An IR-induced crosslink between thymine and tyrosine (taken from [44]).

The timing of this review coincides with the emergence of proteomics as a tool for studying biological complexes involving unknown proteins, so that the identification and quantification of specific proteins that become crosslinked to DNA is now possible without the necessity for presumption. This approach has been recently highlighted because of its success in identifying proteins involved in complex cellular structures such as the spliceosome [1] and lipid rafts [2]. Such studies have highlighted an important issue that may have compromised earlier studies of this type, namely that of protein abundance and solubility under a given set of assay conditions, which may greatly influence the proteins that are identified to the exclusion of others. These issues may have contributed to discrepancies among earlier studies.

Two classes of DPC, the attachment of topoisomerases to DNA and the association of DNA and protein caused by hyperthermia, have been reviewed recently [3] and [4], and will not be discussed in depth in this review.

2. Detection of DPCs

Early studies of DPCs tended to focus on the issue of whether cellular protein became associated with DNA and quantifying these DPCs following exposure of a test system to a given genotoxic agent. Existing techniques for the quantitation of DPCs differ in their detection limit/sensitivity level and associated problems. DPC induction can be measured using the comet assay because the crosslinking of proteins to DNA retards the migration of DNA fragments, resulting in a reduced tail moment [5] and [6]. However, this method does not allow for isolation of DPCs. Gradient separation methods (e.g., CsCl, sucrose) [7] and [8] separate most DPCs from the bulk of the DNA and protein by density, but DPCs are found throughout the DNA and protein fractions [9].

A filter-based DPC isolation method employing nitrocellulose membranes is useful for obtaining dose response curves for total DNA–protein binding based on DNA retention, but is not useful for the identification of specific proteins involved in DPCs because nitrocellulose binds all cellular proteins [10], [11] and [12]. A method developed by Zhitkovich and Costa [13] and [14] measures DPC induction as the extent of DNA associated with protein after the protein is precipitated using sodium dodecyl sulfate/potassium (SDS/K+). However, SDS/K+ precipitation is expected to result in the precipitation of some non-covalently linked proteins because SDS binds selectively to proteins and is then precipitated (with bound DNA) by the potassium.

An alternative approach to DPC quantitation is to isolate DNA and measure the associated protein. The alkaline elution assay traps high molecular weight DNA (with attached proteins) on a polycarbonate filter while non-covalently bound proteins are washed away [15] and [16]. However, recovering DPCs from the filters is difficult and poorly reproducible. Total genomic DNA can be isolated using a chaotrope/detergent mix and ethanol precipitation. This DNA isolation method can be combined with additional steps to stringently dissociate non-covalent protein–DNA complexes to allow the isolation of proteins truly crosslinked to the DNA. Modifications of this method have been used to isolate and identify nuclear matrix proteins crosslinked to DNA by cisplatin [17] and [18].

The lack of stringency of DPC isolation methods has been part of the problem in assessing the biological relevance of DPC analyses to date. It is known that nuclear matrix proteins are tightly associated with the DNA; their complete dissociation is crucial for the identification of those proteins that are covalently crosslinked to DNA by a given agent. As well, proteins are usually crosslinked at low levels, and it can be difficult to isolate sufficient quantities for the sequencing of proteins for identification. Detection limits of the various techniques have contributed to variability in results. Several studies have made use of two-dimensional polyacrylamide gel electrophoresis (2-D PAGE) to analyze proteins present in crosslinked samples or in nuclear matrix fractions [8], [17], [18], [19], [20], [21] and [22], but this technique does not itself identify the proteins. However, the emerging field of proteomics, which combines the separating capacity of 2-D PAGE analysis with powerful protein sequencing technology, should greatly facilitate the identification of these proteins.

3. Chemical-induced DPC formation

3.1. Formaldehyde-induced DPCs

Formaldehyde is a widely studied DPC-inducing agent, and the crosslinking of proteins to DNA by formaldehyde is used for the investigation of DNA–protein interactions in a technique called chromatin immunoprecipitation (ChIP). To perform ChIP, cells are treated with formaldehyde resulting in the covalent crosslinking of proteins to the DNA sequences with which they are associated. The DNA is then fragmented and the protein–DNA complex is isolated by immunoprecipitation with an antibody to the protein of interest.

Formaldehyde can react with amine, thiol, hydroxyl, and amide groups to form various types of adducts, but the major class of DNA lesions induced by this compound are DPCs (reviewed in [23] and [24]). DPC induction involves the reaction of formaldehyde with amino and imino groups of proteins (e.g., lysine and arginine side chains) or of nucleic acids (e.g., cytosine) to form a Schiff base, which then reacts with another amino group (Fig. 2) [25] and [26].



Fig. 2. Formaldehyde crosslinking mechanism. This figure depicts the steps in the reaction of formaldehyde with an amino group (e.g., of a protein side chain) to form a Schiff base (in step 1) which can then go on and react with another amino group (of a DNA base) to complete the crosslink.

3.2. Metal-induced DPCs

Among the DPC-inducing agents commonly found as environmental and workplace pollutants are a number of metal compounds. DPCs induced by nickel compounds have been suggested to involve oxidative mechanisms [27] and [28]. Nickel ions have a high affinity for proteins, especially for histidine, cysteine, and aspartic acid residues [27] and [28]. In one study [27], DPCs were isolated by SDS/K+ precipitation from rat lymphocytes treated with various nickel compounds. Co-incubation of lymphocytes with nickel compounds and either metal chelators, free amino acids, or scavengers of reactive oxygen species (ROS) all decreased the yield of DPCs.

Analysis of metal ion-induced crosslinks demonstrated that not all putative DPCs are due to covalent linkages [22] and that one agent can induce more than one chemical type of crosslink. DPCs were induced in human leukemic cells or isolated nuclei by treatment with potassium chromate, chromium (III) chloride or IR. DPCs were isolated by SDS/K+ precipitation/ethanol precipitation and analyzed by 2-D SDS-PAGE. Some crosslinked proteins were liberated by treatment with EDTA, indicating that they were not covalently crosslinked to DNA but rather were bound to DNA through a chelatable form of chromium. Some crosslinked proteins were liberated by treatment with thiourea, indicating that they were crosslinked to DNA through a sulfhydryl linkage. The majority of IR-induced DPCs were not reversed by EDTA or thiourea treatment and were only released from the DNA by DNase I digestion, and likely represent covalent crosslinks formed through oxidative mechanisms. Some of the DPCs induced by chromate were also resistant to EDTA or thiourea treatment, and were thus likely to be covalent linkages formed via ROS.

Zhitkovich et al. [29] reported that a considerable proportion ( 50% at biologically relevant doses) of chromium–DNA adducts were in fact DNA–metal–protein complexes. The amino acids most frequently involved in these complexes were cysteine, histidine, and glutamic acid. Reactions of cysteine or histidine with trivalent or hexavalent chromium were analyzed, and it was shown that Cr(VI) must be reduced to Cr(III) and that Cr(III) must first complex with an amino acid before reacting with DNA to form the crosslink. No complex was formed between DNA and amino acid if the DNA alone was first incubated with Cr(III) and then separated from unreacted Cr(III) and reacted with protein. Additionally, these investigators reacted the Cr(III)–histidine complex with nucleosides and nucleotide monophosphates and showed that nucleotides could participate in crosslinks but nucleosides could not, indicating that the phosphate group is essential for the crosslinking reaction. However, this crosslinking utilized free amino acid and free nucleotide and thus may not be identical to that which would occur in vivo. The different types of linkages seen with chromium treatment (chelation complexes, sulfhydryl linkages, and linkages generated by ROS) raise the interesting question as to whether other DPC-inducers can generate more than one type of crosslink and what factors might influence the spectrum and yield of various types of crosslinks produced by a given agent.

4. DPCs induced by IR and ROS

4.1. Radiation-induced DPCs in cells

Exposure of cells to IR results in the generation of many localized ROS within a short distance of each other and of the DNA (Fig. 3). Many of these, including the extremely reactive hydroxyl radical ( OH), will be generated at high levels within small discrete regions known as spurs, blobs, and short tracks [30]. When these ionization-dense regions overlap a DNA molecule, this can result in what are variously referred to as “locally multiply damaged sites” or “clustered lesions”, because each radical within the region can potentially generate damage to the DNA. The result is multiple types of damage—single strand breaks (SSBs), double strand breaks (DSBs), base damage or base loss, DNA–DNA crosslinks, and/or DPCs—generated within a short distance of each other in the DNA. Most studies of the biological effects of the cellular lesions induced by IR have focused on DSBs, and not much attention has been paid to the DPC. However, measurements of the amounts of each type of damage induced per mammalian cell per unit absorbed dose of IR reveal that the yield of DPCs ( 150/cell per Gy) is actually higher than that of either DSBs (20–40/cell per Gy) or DNA–DNA crosslinks ( 30/cell per Gy) [31].



Fig. 3. Generation of ROS by IR: IR can directly ionize DNA or protein in its path generating DNA or protein radicals. Indirectly ionizing events include the ionization of water molecules surrounding the DNA or protein generating the reactive hydroxyl radical ( OH), which can then react with DNA or protein, rendering it reactive. The dashed circle represents a spur (Section 4.1) [30]. The shaded globules represent proteins.

Early studies by Fornace and Little [32] and [33] using alkaline elution demonstrated the induction of DPCs in aerated human cells exposed to very high doses of X-rays. They also showed an increase in DPC induction efficiency under hypoxic conditions. A similar observation was made by Meyn et al. [34] and [35] using Chinese hamster ovary (CHO) cells and by Radford [36] using mouse L cells, again using alkaline elution, and by Xue et al. [11] in V79 hamster cells using a filter binding assay. Zhang et al. [37], [38] and [39] suggested that negligible levels of DPCs are formed at oxygen concentrations above 1%, that there is maximal DPC induction at oxygen concentrations below 0.1%, and that oxygenated cells are 10–100-fold less susceptible to forming DPCs than hypoxic cells. Similarly, vanAnkeren, Murray, and Meyn (unpublished data) examined the relationship between oxygenation and DPC induction in CHO cells exposed to γ-radiation and found that the yield of DPCs decreases as oxygen levels increase (Fig. 4). Several other studies have also shown a marked increase in cellular DPCs induced by IR under hypoxic conditions [40], [41], [42], [43] and [44].



Fig. 4. Oxygen dependence of DPCs (squares) and survival (triangles) in γ-irradiated AA8 CHO cells. DNA–protein crosslinks were measured by the alkaline elution assay and cell survival was measured by colony-forming assay. The x-axis represents the percent oxygen in the gassing mixture. Single-cell suspensions were stirred at 4 °C while being gassed with a mixture of 5% CO2, varying concentrations of O2, balance N2, for 3 h prior to irradiation.

Zhang et al. [38] showed that pH, nutrient depletion, temperature, and growth phase did not significantly influence the yield of IR-induced DPCs in aerated normal and tumor cells as measured by alkaline elution. Similarly, pH and nutrient status had no effect on cellular DPC induction when oxygen was absent [45]. Importantly, Zhang et al. [38] pointed out that it is difficult to compare DPC studies as the various techniques used to measure DPCs differ in their detection limits.

Given that the yield of DPCs in cells decreases markedly as oxygen is introduced, whereas the effect of oxygen on IR-induced cell killing goes in the opposite direction, and because the yield of other types of DNA damage such as DSBs closely parallels cell killing under these conditions, the role of DPCs in the biological effects of IR has been largely disregarded. However, as will be discussed in Section 9, these lesions may contribute to the radiosensitivity of hypoxic cells if their repair is compromised.

The situation with respect to DPCs and high linear energy transfer (LET) radiation has received some theoretical consideration. One unresolved question is whether DPCs, either alone or in association with clustered lesions, might differentially contribute to cell killing induced by radiations of differing LET. The thinking is that higher LET tracks will generate more complex clustered lesions, possibly with a higher probability of involving a DPC. Putative high-LET “specific” lesions could include complex clustered-damaged sites wherein DSBs are associated with DPCs [46], [47] and [48]. Some experimental studies have addressed the issue of whether the yields and/or repair of DPCs might differ with LET. Blakely et al. [49] showed that the initial DPC yields in normal hamster cells were similar for X-rays and high energy Ne-ions of 32, 100, and 183 keV/μm at low doses, although N-ions (120 keV/μm) generated a lower DPC yield. Another study suggests that a high-LET beam of N-ions appeared to induce higher levels of residual (6 h post-IR) DPCs per unit dose than low-LET X-rays in human melanoma cells (data from Eguchi et al. [50], re-calculated by Frankenberg-Schwager [51]). This difference may be attributable to the above-mentioned induction of more complex lesions at higher LET, rendering DPCs more difficult to repair.

4.2. Radiation-induced DPC structures

To understand the cellular consequences of DPCs and to investigate their possible repair pathways, it will be important to delineate the chemistries of these linkages (Fig. 1). Extensive work with cell-free models has demonstrated the covalent nature of IR-induced DPCs, and the chemical structure of some DPCs has been determined using gas chromatography/mass spectrometry (GC/MS) analyses [52], [53] and [54]. These reports examined γ-irradiated aqueous mixtures of thymine and amino acids (lysine, glycine, alanine, valine, leucine, isoleucine, tyrosine, and threonine) and demonstrated that particular DNA–amino acid crosslinks exist as several isomers [52], [53] and [54]. The involvement of these amino acids in DPCs was also shown in vitro in isolated irradiated mixtures of calf thymus nucleohistone [52], [53] and [54].

The GC/MS experiments were extended to analyze the formation of DPCs in vivo using cultured mammalian cells [44] and [55] and rat renal tissue [56]. These samples were treated with ferrous ions, hydrogen peroxide, or IR, and the chromatin was isolated, subjected to acid hydrolysis, and analyzed by GC/MS. Crosslinking of DNA to protein through a thymine–tyrosine linkage was detected in these samples. In both the in vitro and in vivo studies, the induction of DNA–amino acid complexes and DPCs increased linearly with IR dose. Hydrogen peroxide treatment of cultured cells also resulted in the concentration-dependent induction of DPCs in chromatin [44]. Addition of radical scavengers/metal chelators (dimethylsulfoxide or o-phenanthroline) partially inhibited DPC formation [44].

Dizdaroglu et al. [54] have proposed that the OH radical is involved in the formation of the crosslink whether these DPCs are induced by ferrous ions, hydrogen peroxide or IR. Free radicals/ROS are also generated through biological redox reactions and under conditions causing oxidative stress, such as malnutrition, numerous disease states, exposure to particular drugs and environmental pollution. The crosslinking mechanism involves H-atom abstraction from the methyl group of thymine by OH, addition of the resultant thymine radical to the carbon-3 position of the tyrosine ring, and oxidation of the resulting adduct radical [54].

Electrospray–ionization mass spectrometry (ESI–MS) analysis of an irradiated solution containing angiotensin and thymine demonstrated the formation of a covalent bond between the methyl group of thymine and C3 of the angiotensin tyrosine ring [57] and also indicated C2 of tyrosine as another major site of bond formation. Crosslinks between thymine and tyrosine were detected at IR doses as low as 0.1 Gy, and the yield of crosslinks was linear up to 100 Gy. Reaction of OH with thymine most frequently resulted in addition to the C5–C6 double bond ( 60% and 30%, respectively, at the 5 and 6 positions), and abstraction of an H-atom from the methyl group occurred only 10% of the time.

It will be of interest to determine if specific proteins found to be covalently crosslinked to DNA in vivo will prove to be linked through any of these identified target residues. Additionally, this information may be of use in predicting which proteins are likely targets for DPC formation because of their amino acid composition and their contact with the DNA. Identifying a crosslinked protein and the residue through which the linkage forms may also provide information on molecular geometry because the DNA and protein must be in close proximity during free radical generation.

4.3. Protein radicals and DPCs

DNA is not the only site of free radical generation or the only target for free radical attack following IR exposure (Fig. 3). Proteins and amino acids are also susceptible to attack by ROS. Indeed, an alternative mechanism for DPC induction involves an initial protein radical created by abstraction of an H-atom by OH from the amino acid, followed by addition of the amino acid radical to the C6 position of thymine and oxidation of the adduct radical [52]. ESI–MS studies by Weir Lipton et al. [57] show that OH adds to the tyrosine ring at C3 50% of the time and at C2 35% of the time. The C3 tyrosine adduct radical then loses water to generate a phenoxyl radical, which can then react with DNA. Thus, a DPC may be formed by the addition of a protein radical to DNA or vice versa, or from a combination of two radicals.

Exposure of proteins to ROS can generate protein hydroperoxides or other reactive protein species as well as additional free radicals. An in vitro study [58] used several purified proteins (insulin, α-casein, apotransferrin, and bovine serum albumin (BSA)) irradiated in aqueous solution in the presence of oxygen or nitrous oxide to generate protein hydroperoxides, and tested these for DPC formation with plasmid DNA based on the retardation of DNA migration on an agarose gel. The observation that inclusion of anti-oxidants did not reduce the yield of DPCs suggested that these lesions were not generated from long-lived radical species produced at the irradiation step. However, the formation of DPCs was reduced by including metal chelators in the reaction, suggesting that at least some of the DPCs were dependent on metal atoms associated with the DNA. Other reports have indicated that proteins that do not bind to DNA (e.g., BSA [59]) cannot generate DPCs in vitro, so there is some question as to whether or not non-DNA binding proteins can be involved in DPCs. It is likely that the conflicting reports reflect variations in in vitro experimental parameters such as DNA and/or protein concentrations, presence of radical scavengers, and presence of salts or metals or reductants that would interfere with the DPC formation reaction.

Further work examining the role of reactive protein species in DPC formation used hypochlorous acid (HOCl), an oxidant that is produced by normal metabolic processes such as phagocyte activity [60]. HOCl can react with protein amino groups, generating chloramines that decompose to protein radicals, which can react with DNA. HOCl can also interact with DNA to form chloramines. Hawkins et al. [60] investigated the formation of DPCs by HOCl in nucleosomes of eukaryotic-cell nuclei using electron paramagnetic spin resonance spectroscopy. The reaction of protein radicals with pyrimidine nucleosides was observed to yield nucleobase radicals, which could result in covalent crosslinking of DNA to protein. These authors [60] suggested that reaction of HOCl occurs predominantly with the protein and not the DNA, and that 50–80% of these reactions are with lysine or histidine residues. The finding that adduct formation was decreased in the presence of radical scavengers suggested that a radical is involved in this reaction.

Similar steps in DPC formation were suggested by analysis of malondialdehyde-induced DPCs in vitro [59]. These investigators reacted malondialdehyde with either protein or DNA in aqueous solution, purified away non-reacted material, and then attempted the second half of the DPC reaction (by introducing DNA or protein). For the formation of a DPC, it was apparent that the malondialdehyde must first react with the protein to generate an adduct that subsequently reacts with the DNA to form the crosslink.

Although both DNA- and protein-radical formation have been suggested as the first step in DPC formation in vitro, it remains to be seen which mechanism predominates in vivo. Both mechanisms are probably operative for various agents, and other factors may influence the levels of each type of radical produced. For example, in the case of IR, the spatial distribution of DNA and proteins in the radiation track may be critical in this regard [48].

5. Stability of DPCs in vitro

Different types of DPCs appear to have very different chemical stability. Aldehyde-induced DPCs are reversed by spontaneous hydrolysis and are also reversible by incubation at elevated temperatures (discussed in [24]). Acetaldehyde-induced DPCs are hydrolytically unstable, and in in vitro experiments only 25% of these DPCs remained after 8 h at 37 °C [61] and [62]. By comparison, malondialdehyde-induced DPCs formed in vitro using purified DNA and histone protein had a much longer half-life of 13.4 days at 37 °C [59].

The lifetime of formaldehyde-induced DPCs in vitro was investigated by Quievryn and Zhitkovich [24] using purified DNA and histone H1. Inclusion of either SDS or 0.8 M sodium chloride with the formaldehyde during the crosslinking reaction reduced crosslinking of histone H1 by preventing its binding to DNA. Addition of SDS after the formaldehyde crosslinking reaction decreased the lifetime of the histone H1–DNA DPC from 26.3 to 18.3 h at 37 °C, suggesting that if the protein is allowed to stay associated with the DNA, the crosslinks can reform under physiological conditions.

6. Biological consequences of DPCs

The covalent crosslinking of proteins to DNA is expected to interrupt DNA metabolic processes such as replication, repair, recombination, transcription, chromatin remodeling, etc. Indeed, the effect of agents that cause DPCs on DNA replication has been widely investigated ([63], [64] and [65] and others). DPCs are expected to act as bulky helix-distorting adducts and would therefore be likely to physically block the progression of replication or transcription complexes and/or prevent access of proteins required either for synthesis along the template strand, for transcription, or for repair recognition and/or incision. They may also affect all of these processes by anchoring the chromatin and preventing its remodeling.

Unfortunately, our understanding of the biological consequences of DPCs is hampered by the fact that no agent exclusively induces these lesions in genomic DNA (although studies using plasmid DNA have provided some insight into the processing of these lesions by cells; see below). Thus, all known DPC-inducing agents generate other forms of DNA damage in addition to DPCs, and direct attribution of any observed effect such as mutagenesis or carcinogenesis to DPCs is inevitably confounded by the concomitant impact of these other lesions. Nonetheless, several studies have reported that the induction of DPCs by many agents correlates with genetic damage such as sister chromatid exchanges (SCEs), transformation, and cytotoxicity [66], [67], [68], [69] and [70]. Thus, DPCs may contribute to the genotoxic effects of many different DNA-damaging agents, some of which are discussed below.

6.1. Nickel

Various types of chromosome damage (DNA gaps and breaks, SCEs and others) have been shown to persist in lymphocytes of nickel workers for years after exposure [71] and [72]. Earlier studies demonstrated an increased incidence of alveolar/bronchial/adrenal medulla neoplasms in rats exposed to nickel compounds [73].

6.2. Chromium

Chromium exposure has been associated with an increased incidence of respiratory cancers (reviewed in [74]). Voitkun et al. [75] used amino acid–chromium–DNA adducts (model DPCs) in a shuttle vector to show that processing of these lesions by human cells can result in mutagenesis. Plasmids containing DNA–Cr(III)–glutathione or DNA–Cr(III)–amino acid adducts were transfected into human fibroblasts, re-isolated after a 48 h incubation, and sequenced. The types of mutations caused by the DPCs were mainly single base substitutions at G:C base pairs, with G:C  A:T transitions and G:C  T:A transversions being induced with similar frequency. Chromium–DNA complexes also resulted in sequence mutations, although this effect was weaker.

The feasibility of using DPCs as biomarkers for exposure to chromium in human cells has been investigated [74]. Higher levels of DPCs were detected in lymphocytes of individuals exposed to chromium compounds than in non-exposed individuals, although the DPC level was found to plateau in individuals exposed to high levels of chromium.

6.3. Arsenic

Arsenic has been implicated in the induction of skin, lung, bladder, and liver cancers [76], [77] and [78]. Although it is carcinogenic, arsenic has not been found to be mutagenic. Earlier studies suggested that arsenic only induces DNA damage at high concentrations; however, a recent study [79] suggests that different cell types differ in their sensitivity to arsenic. Arsenic does in fact induce DNA damage at concentrations that are biologically relevant, the major forms of arsenic-induced DNA damage being oxidative DNA adducts and DPCs [79]. As well, multiple pathways have been proposed for arsenic-induced cytotoxicity [79]. Treatment with arsenite may result in DNA damage through the production of HOCl because there is an activation of NADH oxidase and an increase in superoxide production after NADH addition in arsenite-treated human vascular smooth muscle cells [80]. This pathway can result in DNA damage because superoxide is converted to hydrogen peroxide by superoxide dismutase, and the resulting hydrogen peroxide can react with chloride ions to form HOCl or with transition metal ions to produce OH [80], [81] and [82].

Evidence that arsenic cytotoxicity may not be due to DNA damage comes from Mei et al. [83]. Similar sensitivity was seen for normal human cells and various DNA repair-deficient cell lines (Xeroderma Pigmentosum (XP), Bloom Syndrome (BS), and Fanconi Anemia (FA)) after treatment with sodium arsenite; however, Ataxia-Telangiectasia (AT) cells were significantly more sensitive. This sensitivity did not appear to be related to DSB repair because additional cell lines defective in DSB repair did not display increased sensitivity to arsenic. As well, there was no induction of DSBs (as measured by histone H2AX phosphorylation) and no activation of p53 upon treatment of normal cells with sodium arsenite. One parameter that did seem to be affected by arsenic treatment was cell cycle distribution. Normal cells showed a significant increase in the percentage of cells in S-phase and a modest increase in the percentage of cells in G2/M phase after arsenic treatment, whereas the cell cycle distribution of AT cells was unaffected. Thus, the sensitivity of AT cells to arsenic may be due to an effect on cell cycle regulation and not necessarily due to DNA damage. However, Bau et al. [79] provided evidence that arsenic induces DPCs that are converted to DSBs over time. Thus, measurements of DSBs and DPCs will be inaccurate as DPCs become converted to DSBs. The disruption of cell cycle seen with arsenic treatment may be due to DPCs. Although there is little knowledge on the effect of DPCs on cell cycle progression, these lesions are expected to disrupt multiple functions of DNA metabolism/organization.

6.4. Formaldehyde

Formaldehyde [HCHO] is the most widely studied DPC-inducing agent. It is mutagenic in bacteria, lower eukaryotes, and human lymphoblasts, inducing primarily point mutations and deletions. Formaldehyde also causes micronuclei [84] and is implicated in the induction of nasal tumors in experimental animals [85] and [86]. The induction of DPCs by formaldehyde has been shown to be dose-dependent and to correlate with tumorigenesis [87] and [88]. The extent of DNA–protein crosslinking has been used as a biomarker of formaldehyde exposure in mammalian cells [87], [89] and [90] and may have similar applicability in assessing risk factors for exposure to other DPC-inducers.

6.5. Methylglyoxal and glyoxal

Methylglyoxal [pyruvic aldehyde: CH3COCHO] is another endogenous aldehyde metabolite known to induce DPCs. It is found widely in food and beverages and in cigarette smoke. Methylglyoxal reacts with free amino acids, proteins, and nucleic acids (mainly guanines) resulting in DNA adducts, strand breaks, DNA interstrand crosslinks, and extensive DNA–protein crosslinking through lysine and cysteine residues [91], including crosslinking of histones (reviewed in [92], [93] and [94]). Mutations induced by methylglyoxal in mammalian cells were predominantly ( 50%) deletions but included a significant proportion of base-pair substitutions ( 35%) [93]. The DNA-damaging effects of methylglyoxal include the induction of SCEs, chromosomal aberrations, and micronuclei [93].

Glyoxal [(CHO)2] is a related, endogenously produced, aldehyde that induces DNA strand breaks but 10-fold fewer DPCs than methylglyoxal. Glyoxal also induces 10-fold fewer frameshift mutations than methylglyoxal, suggesting that DPCs might be the cause of these events (which are a common result of bulky adducts) [94]. Roberts et al. [94] compared the effects of glyoxal and methylglyoxal on human skin cells using both the comet assay and an in vitro plasmid assay. In the comet assay, the tail moment increased when cells were treated with glyoxal, indicating DNA strand breakage. However, following methylglyoxal treatment, there was compaction of the nucleus and reduced migration, indicating the presence of DPCs.

6.6. Pyrrolizidine alkaloids

Pyrrolizidine alkaloids are cytotoxic compounds found in many plant species that are used in herbal remedies and teas. These compounds can cause liver disease and are carcinogenic [95]. They are metabolically activated and form DPCs and DNA interstrand crosslinks in similar proportions when assessed by alkaline elution [96]. The cytotoxic and anti-mitotic activities of pyrrolizidine alkaloids correlates with their ability to form both DPCs and interstrand crosslinks [96], [97] and [98].

6.7. Ionizing radiationAs noted in Section 4.1, the role of DPCs in the biological effects of IR has been largely ignored because these lesions are more abundant following irradiation in the absence of oxygen, a condition that is protective for most other IR-induced end-points such as cell killing and mutation. Certainly, this observation suggests that DPCs are minor lesions in irradiated oxygenated cells. However, there is some evidence that DPCs can contribute to the killing of mammalian cells when their repair is inhibited. In particular, certain DNA repair-deficient hamster cell lines such as UV41 (XPF?) and UV20 (ERCC1?) (reviewed in [99] and [100]) are significantly more sensitive than wild-type cells to killing by IR under hypoxic conditions, a phenotype that has been attributed to a deficiency in the repair of DPCs [100].

It should be noted that many human tumors contain a significant proportion of hypoxic cells, and this represents a problem in the use of radiation therapy for cancer treatment because hypoxic cells are more resistant to IR-induced killing. The findings that DPCs are induced by IR to a greater extent in hypoxic versus aerated cells and that certain repair deficiencies specifically increase the radiosensitivity of hypoxic cells might provide an avenue for improving radiation therapy if the repair of DPCs can be effectively inhibited.

6.8. Cumulative/background lesions

DPC accumulation may be associated with breast cancer [101]. The base-level of DPCs, presumably caused by environmental factors and metabolic byproducts, was found to be significantly elevated in breast cancer patients compared to healthy individuals. It is far from clear, however, whether these DPCs are secondary to the many cellular changes that accompany cancer development or treatment or if these DPCs are in fact causative in breast carcinogenesis.

7. Proteins involved in DPCs

Determining which proteins become crosslinked to DNA by these various genotoxic agents and how they are bound may help to unravel the biological consequences of DPCs as well as the mechanisms of their repair. A number of investigators have tried to identify proteins that can become crosslinked to DNA using in vitro systems with purified proteins and DNA or by isolating DPCs from cells exposed to various DNA-damaging agents. Several proteins have been shown to be amenable to crosslinking in vitro when they are combined with DNA and treated with a DPC-inducing agent, although the relevance of this information to the in vivo situation is uncertain. Some reports suggest that only DNA-binding proteins can be crosslinked to DNA, while others suggest that any protein can become crosslinked to DNA. Potentially biologically-relevant proteins that have been shown to be crosslinked to DNA in vivo include actin, lectin, aminoglycoside nucleotidyl transferase, histones, a heat shock protein (GRP78), cytokeratins, vimentin, protein disulfide isomerase, and transcription factors/co-factors (estrogen receptor, histone deacetylase 1, hnRNP K, HET/SAF-B) (Table 1) [7], [18], [19], [22], [102], [103], [104] and [105].

Table 1.

Proteins identified in DNA–protein crosslinks

Protein

Crosslinking agent

Reference

Actin

Chromium

[19] and [22]

 

Cisplatin

[106]

 

Mitomycin C

[106]

 

Pyrrolizidine Alkaloids

[106]

Lectin

Chromium

[22]

Aminoglycoside nucleotidyl transferase

Chromium

[22]

Histones H1, H2A, H2B, H4

Formaldehyde

[104]

Histone H3

Formaldehyde

[104]

 

Gilvocarcin V

[102]

Glucose regulated protein 78

Gilvocarcin V

[102]

Cytokeratins

Arsenic

[103]

Vimentin

Formaldehyde

[7]

 

Metabolic byproducts

[7]

Protein disulfide isomerase

Cisplatin

[105]

Estrogen receptor

Cisplatin

[18]

HET/SAF-B

 

 

hnRNP K

 

 

Histone deacetylase 1

 

 

Actin was shown to be crosslinked to DNA in human leukemic cells or isolated nuclei treated with chromium compounds or IR [21] and [22]. DPCs were isolated by SDS/K+-urea precipitation/ethanol precipitation, followed by analysis by 2-D SDS-PAGE. In this study, 20 proteins were found to be crosslinked to DNA by chromium and IR. Three of these were identified as actin, aminoglycoside nucleotidyl transferase, and lectin. Similarly, Miller et al. [19] demonstrated the crosslinking of actin to DNA in hamster cells exposed to chromium or cisplatin. DPCs were isolated by SDS/K+-urea precipitation/acetone precipitation. DNA was digested with DNase I, and the isolated proteins were analyzed by SDS-PAGE. This procedure isolated several proteins, one of which was identified as actin on the basis of molecular weight and pI, and confirmed using immunological methods. Actin–DNA crosslinks comprised 20% of the total DPCs isolated. Additional proteins were found to be crosslinked by chromium at higher metal concentrations.

Actin was also found to be crosslinked to DNA by pyrrolizidine alkaloids [106]. Bovine kidney cells and human breast cancer cells were treated with these compounds, and DPCs were isolated by repeated extraction/precipitation with SDS and urea. Crosslinked proteins were released from the DNA by DNase I digestion and analyzed by SDS-PAGE. Participation of different isoforms of actin in DPCs was confirmed by immunoblotting. Actin was also identified as a component of DPCs isolated from cells treated with cisplatin or mitomycin C. Another study [105] demonstrated the cisplatin-induced crosslinking of at least four proteins to DNA in human cells and identified protein disulfide isomerase as one of these using immunological methods. If the association of proteins with DNA was disrupted by extracting the cells with dithiothreitol prior to cisplatin treatment, protein disulfide isomerase was no longer crosslinked. Several proteins have been shown to be crosslinked to DNA by arsenic [103]. DPCs were isolated from arsenic-treated cultured human hepatic cells using SDS/K+ precipitation (without urea). Crosslinked proteins were separated by SDS-PAGE, and the presence of several different cytokeratins was confirmed using antibodies. However, these arsenic concentration-dependent crosslinks could be reversed by high salt, suggesting that they may be non-covalent associations rather than true covalent DPCs.

One protein identified as being closely associated with DNA in vivo by virtue of its susceptibility to crosslinking by formaldehyde is vimentin, which is a structural/scaffold protein [7]. DPCs were isolated from formaldehyde-treated mouse and human cells by sucrose gradient sedimentation followed by repeated SDS/K+ precipitation/ethanol precipitation, followed by immunoprecipitation using anti-vimentin antibodies. The vimentin could be released from the DPC by boiling, which may indicate thermolability of the crosslinkage or a non-covalent association. Vimentin DPCs were also observed in oxidatively-stressed and senescent cells, indicating that metabolic byproducts can crosslink this protein to DNA.

Gilvocarcins are naturally occurring anti-tumor antibiotics that can crosslink proteins to DNA. Normal human fibroblasts treated with gilvocarcins were subjected to lysis and DPC isolation using SDS/K+ precipitation with a sodium chloride wash step, followed by immunoprecipitation with an antibody to double stranded DNA [102]. The DPCs were separated by SDS-PAGE, and two proteins—histone H3 and heat shock protein GRP78—were identified by amino-terminal amino acid sequencing and confirmed by immunoblotting [102].

There are conflicting reports regarding the involvement of histones in DPCs. Several investigations have focused on the in vitro induction of histone-involving DPCs in aqueous solution. Miller et al. [19] treated a combination of purified actin or histone and bacteriophage DNA with chromium compounds in vitro and found that histones were not as efficiently crosslinked to DNA as actin. This may be due to the fact that chromate has a high affinity for sulfhydryl groups and thus induces crosslinks through a sulfhydryl linkage, but there are few sulfhydryl groups in histone proteins [21]. However, histones have been found to be readily crosslinkable to DNA by formaldehyde through an amine to amine linkage [104], [107] and [108] and mammalian histones can be crosslinked to DNA by treatment with aldehydes both in treated cells and in cell-free systems [24], [59], [61], [109] and [110]. The choice of DPC-inducing agent may explain why some studies found histones to be highly crosslinked to DNA while others did not.

Induction of DNA–histone crosslinks by IR has proven controversial. Several studies [52], [53] and [54] have shown the IR dose-dependent crosslinking of histones to DNA in vitro using calf nucleohistone. Studies from Xue et al. [111] and Oleinick et al. [112] using irradiated hamster cell nuclei demonstrated that DPCs were induced in histone-depleted chromatin [112] and that extraction of nuclei with 1.6 M NaCl showed little depletion of DNA-associated histones but was associated with a significant decrease in DPC induction, indicating that other proteins are involved in these DPCs [111]. However, Mee and Adelstein [41] also examined the induction of DPCs by γ-radiation using chromatin isolated from Chinese hamster lung fibroblasts and obtained different results. They suggested that the core histones (H2A, H2B, H3, and H4) are in fact the major proteins involved in DPCs because they observed no difference in induction of DPCs between in vitro-prepared whole chromatin and chromatin stripped of other nuclear matrix proteins. These contradictory results may be due to differences in the efficiencies of the extraction procedures, and thus the true extent of the involvement of histones in DPCs is yet to be resolved.

The conflicting data on the formation of histone–DNA crosslinks may reflect the fact that these studies used different methods of inducing, isolating, and quantitating DPCs. Given that DPC-inducing agents have different mechanisms of action, it is possible that histones are substrates for only some types of reactions. Different methods of isolation and analysis may result in a failure to detect crosslinked proteins of low abundance, and detectability may be affected by the solubilities of these proteins. These types of problems are also likely to affect the analyses of other proteins involved in DPCs.

Like the histone proteins, high mobility group (HMG) proteins are likely targets for DPC induction given that they are highly abundant and frequently associated with DNA. These proteins have roles in modifying the compaction of the chromatin fiber, promoting access to nucleosomes, and stimulating transcription and replication [113], [114], [115] and [116]. Additionally, the high affinity of HMG proteins for unusual structures (e.g., chromium-damaged, cisplatin-damaged DNA) may also predispose them to crosslinking. There is little evidence for the involvement of HMG proteins in DPCs. HMG proteins were shown to be crosslinked in vitro to a synthetic nitric oxide-damaged DNA substrate [117] (as discussed in Section 7.1). It has been shown [118] and [119] that a novel anti-tumor drug (FR-66979) covalently crosslinks a DNA duplex with a synthetic peptide corresponding to the HMGA (formerly HMGI/Y [120]) binding domain. Extending this work, Beckerbauer et al. [121] reported the crosslinking of HMGA and of HMGB1 and HMGB2 (formerly HMG1 and HMG2 [120]) to DNA in vivo by a related drug (FR900482). Complexes of HMGA and DNA were isolated from drug-treated cells but not control cells using a modified ChIP procedure and HMGA antibodies. In this study, the “crosslinked” protein was released from the DNA by proteinase K digestion, making it difficult to determine if these complexes were in fact covalent. Although the affinity of HMGB1 for undamaged DNA is very weak, it does have very high affinity for unusual DNA structures [113]. HMG proteins bind tightly to chromium-damaged DNA and HMG–Cr–DNA complexes are stable in 0.5 M NaCl [122], and the affinity of HMGB2 for cisplatin-modified DNA is 10-fold stronger [123].

The question of whether or not HMG proteins are involved in DPCs requires further investigation. HMG proteins are known to be extremely mobile [113], [114], [115] and [116] and, although they are highly abundant and frequently associated with DNA, their association with DNA could be too transient for them to be “trapped” in the crosslinking reaction. The above-mentioned affinity of these proteins for damaged DNA may favor such reactions during extended treatments, increasing the likelihood of a crosslinking event.

7.1. Crosslinking of DNA replication/repair enzymes to DNA

The potential for crosslink formation between DNA replication/repair proteins and the substrate DNA has been demonstrated by in vitro experiments. HOCl is capable of crosslinking purified DNA single-stranded binding protein to single-stranded oligonucleotides in vitro [124]. Methylglyoxal was similarly shown to crosslink purified Klenow fragment to a synthetic DNA substrate [93]. The 2-deoxyribonolactone lesion is an abasic site produced by a variety of DNA damaging agents, including IR. This lesion and its β-elimination product were prepared in a synthetic substrate and incubated in separate reactions with protein (Escherichia coli endonuclease III, endonuclease VIII, FPG (formamidopyrimidine glycosylase), or NEIL1 (a mammalian DNA glycosylase [125])) resulting in the crosslinking of each of these proteins to the lesions [126]. Another study demonstrated that the 2-deoxyribonolactone lesion could be crosslinked to DNA polymerase β [127].

Nitric oxide (NO) is a product of inflammation, and chronic inflammation is a known risk factor for many cancers. NO-induced damage includes DPCs [128], [129] and [130]. One type of DNA damage